Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Advances in Cancer Research|June 5, 2026
Zika virus as an oncolytic therapyEric Hawley, Milan G ChhedaComprehensive Reviews in Food Science and Food Safety|April 20, 2023
Enhancing traceability of wheat quality through the supply chainMohammad Nadimi, Eric Hawley, Jing Liu, et al.Gene|April 24, 2012
Cloning and expression of a zebrafish 5-HT(2C) receptor geneHenning Schneider, Luke Fritzky, Jesse Williams, et al.Pharmaceutical Medicine|December 28, 2020
Building a Data Linkage Foundation for Mother-Child Pharmacoepidemiology ResearchChristine C Whitmore, R Eric Hawley, Jea Young Min, et al.JCI Insight|September 22, 2020
Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signalingZhiguo Chen, Stephen Li, Juan Mo, et al.The Journal of Biological Chemistry|May 31, 2020
Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1Julie A Mund, SuJung Park, Abbi E Smith, et al.Human Molecular Genetics|June 2, 2021
PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2)Eric Hawley, Jeffrey Gehlhausen, Sofiia Karchugina, et al.Human Molecular Genetics|October 19, 2018
A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomasJeffrey R Gehlhausen, Eric Hawley, Benjamin Mark Wahle, et al.Arthritis Research & Therapy|May 9, 2020
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNFYun-Jeong Song, In Ah Choi, Françoise Meylan, et al.Plos One|July 15, 2021
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALKLong-Sheng Chang, Janet L Oblinger, Abbi E Smith, et al.Pageof 1